Santé Canada approuve un nouveau vaccin de Novavax contre la COVID-19

Health Canada authorized Novavax's updated COVID-19 vaccine targeting the XBB.1.5 variant on Tuesday. A kidney dish with syringes containing the Novavax COVID-19 vaccine sits in a refrigerator ready for use at a vaccination center in Prisdorf, Germany, Saturday, Feb. 26, 2022. THE CANADIAN PRESS/AP-dpa, Georg Wendt

OTTAWA - Health Canada authorized Novavax's updated COVID-19 vaccine targeting the XBB.1.5 variant on Tuesday.

"Today's expanded authorization will support the Canadian government's strong commitment to provide its citizens with effective options, such as our protein-based non-mRNA vaccine, in the campaign against currently circulating COVID-19 variants," said John C. Jacobs, president and CEO of Novavax in a news release issued Tuesday afternoon.

°µÍø½ûÇø. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from °µÍø½ûÇø News in your inbox. Select the emails you're interested in below.